MIVSET
Live / Applied — Non-final action mailed (as of 26 Mar 2026)
What this means for you
Not registered yet, but its 20 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99507779
- Mark type
- Stylized text
- Filed
- 20 Nov 2025
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals for the treatment of autoimmune diseases; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease; pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders
Owner
- Kyverna Therapeutics, Inc., Emeryville, CA, US
Prosecution history
- 26 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Mar 2026 — NON-FINAL ACTION E-MAILED
- 26 Mar 2026 — NON-FINAL ACTION WRITTEN
- 26 Mar 2026 — ASSIGNED TO EXAMINER
- 20 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — NEW APPLICATION ENTERED